Cantor Fitzgerald analyst Sarah James maintains Nyxoah (NASDAQ:NYXH) with a Overweight and lowers

Piper Sandler analyst Adam Maeder reiterates Nyxoah (NASDAQ:NYXH) with a Overweight and lowers th

Nyxoah SA (NYXH) Q2 2026 Earnings Call Transcript

Nyxoah NASDAQ: NYXH reported second-quarter worldwide net revenue of €7.7 million, up 21% sequential

Nyxoah (NASDAQ:NYXH) lowers FY2026 sales outlook from $42.156 million-$46.840 million to $41.852 mil

Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.67) per share which missed the analyst consens

REGULATED INFORMATION Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Resu

Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 Mont-Saint-Guibert, Belgiu

Nyxoah NASDAQ: NYXH used its investor day presentation to outline early U.S. launch progress for its

Nyxoah SA (NYXH) Analyst/Investor Day Transcript

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical te

Nyxoah Announces Preliminary Results for the Second Quarter of 2026 Continued U.S. launch momentum d

Gainers Seer (NASDAQ:SEER) shares rose 32.1% to $2.14 during Monday's pre-market session. The m

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert

REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium

Nyxoah to Host Investor Day in New York on July 8, 2026 Leadership team and Board will discuss the U

REGULATED INFORMATIONJune 19, 2026, 10:30pm CET / 4:30pm ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH

INFORMATIONS RÉGLEMENTÉESLe 19 juin 2026, 22:30h CET / 16:30h ET NYXOAH SA(Euronext Brussels/Nasdaq:

REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical te

Nyxoah Receives $15 Million from the European Investment Bank Non-dilutive debt funding complements

Stifel analyst Jonathan Block maintains Nyxoah (NASDAQ:NYXH) with a Hold and lowers the price tar

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert

Financing and Leadership Transition Highlights$110 million in new capital$95 million in equity finan

$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch Mont-Saint-Guibert

REGULATED INFORMATION Nyxoah Announces Closing of Underwritten Public Offering Mont-Saint-Guibert, B

Nyxoah (NYXH) raises $95M via public offering to fund U.S. commercial growth and Genio system R&

Nyxoah Announces Pricing of $95 Million Underwritten Public OfferingMont-Saint-Guibert, Belgium – Ju

INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces Pricing of $95 Million Underwritten Public

Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical te

INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces Proposed Offering of Ordinary Shares Mont-

Piper Sandler analyst Adam Maeder reiterates Nyxoah (NASDAQ:NYXH) with a Overweight and lowers th

Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.43) per share which beat the analyst consensus

Wall Street analysts changed outlook on top names. Check rating changes on Benzinga's analyst ra

Stifel analyst Jonathan Block downgrades Nyxoah (NASDAQ:NYXH) from Buy to Hold and lowers the pri

Stifel analyst Jonathan Block maintains Nyxoah (NASDAQ:NYXH) with a Buy and lowers the price targ

Cantor Fitzgerald analyst Sarah James reiterates Nyxoah (NASDAQ:NYXH) with a Overweight and maint

Stifel analyst Jonathan Block maintains Nyxoah (NASDAQ:NYXH) with a Buy and lowers the price targ

Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.68) per share which missed the analyst consens

Stifel analyst Jonathan Block maintains Nyxoah (NASDAQ:NYXH) with a Buy and lowers the price targ

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical te

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical te